Heather  Bradley

Heather Bradley is an Associate Professor of Epidemiology at the Emory Rollins School of Public Health. She is an infectious disease epidemiologist whose main research interests include surveillance methodology, racial disparities in HIV and hepatitis C infections, and the intersection of infectious diseases with the U.S. opioid epidemic. During the past few years, her research focus has grown to include racial disparities in COVID-19 outcomes as well as the health of people who inject drugs (PWID). She previously served on the faculty at Georgia State University School of Public Health. Prior to that appointment, Dr. Bradley spent eight years at the Centers for Disease Control and Prevention in positions ranging from Epidemic Intelligence Service (EIS) Officer to Associate Chief for Science in the Division of HIV/AIDS Prevention. 

Current projects:

Title: Increasing representation of Black communities in COVID-19 home testing and surveillance data (Represent ATL 2.0)

Funding agency: NIH, National Institute on Minority Health and Health Dispartities (U01MD018313); Project period: 11/01/22 – 10/31/24

Description: In this study, we are assessing knowledge and attitudes about COVID-19 home testing among diverse Black communities in Atlanta, GA, including willingness to self-collect a nasal specimen alonside traditional home testing and mail it to a laboratory for PCR testing, which facilitates reporting of results to surveillance.

Title: Increasing representation of Black communities in SARS-CoV-2 serosurveys by understanding barriers and motivations for participation (Represent ATL)

Funding agency: NIH, National Institute on Drug Abuse (3R01DA051302); Project period: 12/01/20 – 05/30/23

Description: This study aims to elucidate barriers and motivations for participating in SARS-CoV-2 research including serosurveys among diverse Black communities in Atlanta, GA.

Title: Estimating the population size of persons who inject drugs in New York

Funding agency: NIH, National Institute on Drug Abuse (R01DA051302); Project period: 04/01/20 – 01/31/25

Description: This study aims to estimate the population size of people who inject drugs (PWID) in New York State using capture-recapture and linked administrative datasets.

Title: Modeling HIV, Viral Hepatitis, STI, and TB to improve public health - CAMP 2.0: The Coalition for Applied Modeling for Prevention 

Funding agency: Centers for Disease Control and Prevention (U38PS004650-01); Project period: 09/30/19 – 09/29/24

Description: As part of a multi-University modeling collaborative, my team is estimating the population size of PWID in the United States and the effects of COVID-19 on HIV and hepatitis C outcomes among PWID.